Feature|Treatment Planning| July 08, 2020 | By Melinda Taschetta-Millane

This article ran as an introduction to ITN'sTreatment Planning Systemscomparison chart in the July/August issue. You can view the charthere.

At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 

At the American Association of Physicists in Medicine (AAPM) 2019 meeting, newartificial intelligence(AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review.

Machine Learning Treatment Planning

RaySearch demonstrated a new U.S. Food and Drug Administration (FDA)-cleared machine learning treatment planning system. TheRaySearch RayStation machine learning algorithmis being used clinically by University Health Network, Princess Margaret Cancer Center, Toronto, Canada, where it was rolled out over several months in late-2019. Medical physicistLeigh Conroy, Ph.D., was involved in this rollout and helped conduct a study, showing the automated plans and traditionally made plans to radiation oncologists to get valuable feedback. She spoke at the AAPM 2019 meeting on this topic.

In an interview withitnTV, Conroy explained that she worked with an algorithm that uses machine learning to create automated treatment plans. “With this, we train the algorithm using a curated set of high-quality, previously delivered plans. Then, it is able to detect the patient that is most similar to a novel patient and create a new treatment plan with no user interaction beyond pressing the play button,” she explained.

Conrad’s study directly compared those automated treatment plans to traditionally generated manual plans. The radiation oncologist then compared those two plans head-to-head and decided whether each plan was acceptable, and chose the favored plan. The plans are not modified as they are performing them, however they are modifiable. “The automated plan is modifiable, but for the purposes of this study, we are not going to be modifying them so we can directly compare the output of the machine learning algorithm to the output of the planners,” she said.

The system was trained using a model that was developed at Princess Margaret, and the model is being used clinically. “The way that we are doing our study is if the doctor does choose the automated plan, then it’s underlined that the physicist knows when they are doing their plan QA that it is an automated plan, and it goes to the same QA that it normally would, and the patient-specific QA is a fully deliverable plan, and that is the plan that the patient is treated with.”

Depending on how things go with the study, it is predicted that AI should see a regular implementation. “That is the point of the study, to make sure we can do this and work it into our regular process and eventually provide it if the doctors continue to like the automated plans,” she said.

One of the main ideas in implementing AI is to save time to get more patient throughput. “We are not measuring the end to end timing of a planner vs. the machine learning. But one of the major advantages is that it takes about 20 minutes for a new patient, however there is no user interacting during those 20 minutes, so the planner can go and do other work or other plans during that time, and come back so there is a fully done plan.”

There is a different process depending on what plan is being created. However, the AI would help to free them up to be able to do other duties. “From a planner expertise perspective, some of the planning techniques such as head and neck might be more complicated so it might take longer for the planner to do it. It’s more reliant on their level of expertise,” she explained.

Other Automated Systems

Varian also has developed AI-driven automated treatment planning software that is currently being used by several hospitals.

Recently, Varian released the newest version of its treatment planning system,Eclipse v16. This new release includes intelligent features such asRapidPlan PT, a clinical application of machine learning in proton treatment planning, and RT Peer Review, a collaborative workspace designed to streamline and accelerate the peer review process for radiotherapy treatment plans.

Previously only available for photon-based radiotherapy treatment planning, RapidPlan is knowledge-based treatment planning software that enables clinicians to leverage knowledge and data from similar prior treatment plans to quickly develop high-quality personalized plans for patients. This knowledge-based planning software is now available for proton treatment planning with RapidPlan PT. The software also allows dose prediction with machine learning models that can be used as a decision support tool to determine which patients would be appropriate for proton or photon therapy.

“With the number of operational proton treatment rooms continuing to increase, there is a need for experienced proton therapy clinicians,” saidKolleen Kennedy质子解决方案公司首席发展官、总裁瓦里安在一份书面声明中表示。RapidPlan PT帮助连接学习曲线,允许已建立的中心分享他们的模型和临床经验。RapidPlan PT中的机器学习有可能将质子治疗计划优化过程从临床质子中心报告的1到8小时缩短到不到10分钟,同时也有可能提高计划的质量。”

Eclipse v16 has received the CE mark and is 510(k) pending.

Related Content:

Artificial Intelligence Greatly Speeds Radiation Therapy Treatment Planning

VIDEO: Use of Machine Learning to Automate Radiotherapy Treatment Planning

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
News|世界杯2022赛程时间表

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

TimeAugust 03, 2022
arrow
The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to grow to $5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.
Feature|Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

TimeAugust 02, 2022
arrow
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer, the leading cancer killer of women and men.
Feature|Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

TimeAugust 01, 2022
arrow
Subscribe Now